Welcome to LookChem.com Sign In|Join Free
  • or
HYODEOXYCHOLIC ACID METHYL ESTER is a light yellow solid that is a cholesterol derivative with hemolytic properties. It is known for its ability to inhibit the oxidation of cholesterol, making it a potentially useful compound in the field of pharmaceuticals and healthcare.

2868-48-6

Post Buying Request

2868-48-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2868-48-6 Usage

Uses

Used in Pharmaceutical Industry:
HYODEOXYCHOLIC ACID METHYL ESTER is used as a cholesterol-lowering agent for its ability to inhibit the oxidation of cholesterol. This application is particularly relevant in the treatment and management of conditions related to high cholesterol levels, such as atherosclerosis and cardiovascular diseases.
Used in Research and Development:
As a cholesterol derivative with hemolytic properties, HYODEOXYCHOLIC ACID METHYL ESTER can be used in research and development for studying the effects of cholesterol oxidation and its role in various diseases. This can lead to the development of new therapeutic strategies and drug candidates targeting cholesterol-related conditions.
Used in Drug Delivery Systems:
Similar to gallotannin, HYODEOXYCHOLIC ACID METHYL ESTER could potentially be incorporated into drug delivery systems to enhance its bioavailability and therapeutic outcomes. This application could involve the use of organic or metallic nanoparticles as carriers for the compound, aiming to improve its delivery and efficacy in treating cholesterol-related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 2868-48-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,6 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2868-48:
(6*2)+(5*8)+(4*6)+(3*8)+(2*4)+(1*8)=116
116 % 10 = 6
So 2868-48-6 is a valid CAS Registry Number.
InChI:InChI=1/C25H42O4/c1-15(5-8-23(28)29-4)18-6-7-19-17-14-22(27)21-13-16(26)9-11-25(21,3)20(17)10-12-24(18,19)2/h15-22,26-27H,5-14H2,1-4H3/t15-,16-,17+,18-,19+,20+,21+,22+,24-,25-/m1/s1

2868-48-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0529)  Methyl Hyodeoxycholate  >98.0%(GC)

  • 2868-48-6

  • 5g

  • 1,550.00CNY

  • Detail
  • TCI America

  • (H0529)  Methyl Hyodeoxycholate  >98.0%(GC)

  • 2868-48-6

  • 25g

  • 4,500.00CNY

  • Detail
  • Sigma

  • (H2517)  Hyodeoxycholic acid methyl ester  ≥98%

  • 2868-48-6

  • H2517-1G

  • 444.60CNY

  • Detail

2868-48-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (4R)-4-[(3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

1.2 Other means of identification

Product number -
Other names 3|A,6|A-Dihydroxy-5|A-cholan-24-oic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2868-48-6 SDS

2868-48-6Relevant academic research and scientific papers

Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor

Yang, Ya-Xi,Zheng, Long-Tai,Shi, Jing-Jing,Gao, Bo,Chen, Yan-Ke,Yang, Hui-Chi,Chen, Hong-Li,Li, Yuan-Chao,Zhen, Xue-Chu

, p. 1222 - 1227 (2014)

Glial activation-mediated neuroinflammation plays a pivotal role in the process of several neuroinflammatory diseases including stroke, Alzheimer's diseases, Parkinson's diseases, multiple sclerosis and ischemia. Inhibition of microglial activation may ameliorate neuronal degeneration under the inflammatory conditions. In the present study, a number of 5α-cholestan-6- one derivatives were prepared and the anti-inflammatory effects of these compounds were evaluated in LPS-stimulated BV-2 microglia cells. Those derivatives were synthesized from readily available hyodeoxycholic acid (1). Among the tested compounds, several analogs (16-18, 25, 35, 38) exhibited potent inhibitory activities on nitric oxide production with no or weak cell toxicity. Compound 16 also significantly suppressed the expression of TNF-α, interleukin (IL)-1β, cyclooxygenase (COX-2) as well as inducible nitric oxide synthase (iNOS) in LPS-stimulated BV-2 microglia cells. In addition, compound 16 markedly reduced infarction volume in a focal ischemic mice model.

Preparation method of chenodeoxycholic acid

-

Paragraph 0089-0096; 0151-0153, (2021/01/24)

The invention relates to the technical field of medicine synthesis, in particular to a preparation method of chenodeoxycholic acid. The invention develops a method for synthesizing the chenodeoxycholic acid by taking hyodeoxycholic acid(3alpha, 6alpha-dihydroxy-5beta-cholanic acid)as a raw material through nine steps of reaction, the reaction conditions of each step are mild, the control is easy,the process is simple, the used raw materials are wide in source, low in price and easy to obtain, the yield is high, the total yield can reach 61%, the synthesis cost is low, and the method is suitable for mass preparation and industrial production.

METHOD FOR HOMOGENIZING BILE ACID DERIVATIVES

-

Paragraph 0083-0085, (2021/05/28)

The present invention relates to a process for producing bile acid derivatives having a protected hydroxyl group in the 3 position comprising contacting a bile acid derivative having an unprotected 3-alpha-hydroxyl group with a specific lipase. The present invention further relates to a bile acid derivative obtained or obtainable by the process, to the use of the bile acid derivative obtained or obtainable by the process for producing lithocholic acid and also to a process for producing lithocholic acid and to lithocholic obtained by the process. The invention further relates to the use of lithocholic acid obtained or obtainable by the process for producing ursodeoxycholic acid or ursodeoxycholic acid derivatives.

Synthesis and biological activity of cyclopropyl Δ7-dafachronic acids as DAF-12 receptor ligands

Carotti, Andrea,Ceccarelli, Giada,Gioiello, Antimo,Goracci, Laura,Mancino, Valentina,Passeri, Daniela,Pellicciari, Roberto,Sardella, Roccaldo

, p. 5403 - 5412 (2021/06/30)

The four cyclopropyl stereoisomers of Δ7-dafachronic acids were prepared from the bile acid hyodeoxycholic acid and employed as chemical tools to exploit the importance of the orientation and spatial disposition of the carboxyl tail and the C25-methyl gro

Efficient synthesis of cholic acid derivates through stereoselective C–H functionalization from hyodeoxycholic acid

Liang, Yu-Yan,Huang, Huan,Li, Yang,Du, Rong-Kai,Li, Jing,Liu, Yong-Hong,Li, Shan,Zhang, Lei

, (2020/02/26)

Five cholic acid derivatives (including allo-ω-muricholic acid and CDCA) were synthesized from hyodeoxycholic acid via selective oxidation of C3- or C6-hydroxyl groups by IBX and NBS oxidants and stereocontrolled conversion. The hydroxyl group could be introduced through hydrolyzing α-Br keto with K2CO3 aqueous solution or through oxidizing the double bond by monoperoxyphthalic acid. The reduction of C6-O6 carbonyl to methylene could undergo with PTSH, NaBH3CN and ZnCl2 only at 5β configuration. A feasible synthetic route of CDCA from HDCA has been established to avoid the epimerization with the yield of 45% (8 steps). These strategies provided good yields, stereoselectivity and reproducibility for the preparation of cholic acid derivates and CDCA.

Synthesis of new cisplatin derivatives from bile acids

?otowski, Zenon,Hryniewicka, Agnieszka,Morzycki, Jacek W.,Rárová, Lucie,Seroka, Barbara,Sicinski, Rafal R.,Tomkiel, Aneta M.

, (2020/02/18)

A series of bile acid derived 1,2- and 1,3-diamines as well as their platinum(II) complexes were designed and synthesized in hope to get a highly cytotoxic compound by the combination of two bioactive moieties. All complexes obtained were subjected to cytotoxicity assays in vitro and some hybrid molecules showed an expected activity.

GPBAR1 activation by C6-substituted hyodeoxycholane analogues protect against colitis

De Marino, Simona,Finamore, Claudia,Biagioli, Michele,Carino, Adriana,Marchiano, Silvia,Roselli, Rosalinda,Di Giorgio, Cristina,Bordoni, Martina,Di Leva, Francesco Saverio,Novellino, Ettore,Cassiano, Chiara,Limongelli, Vittorio,Zampella, Angela,Festa, Carmen,Fiorucci, Stefano

supporting information, p. 818 - 824 (2020/07/02)

GPBAR1 agonists have been identified as potential leads for the treatment of diseases related to colon inflammation such as Crohn's and ulcerative colitis. In this paper, we report the discovery of a small library of hyodeoxycholane analogues, decorated at C-6 with different substituents, as potent and selective GPBAR1 agonists. In vitro pharmacological assays showed that compound 6 selectively activates GPBAR1 (EC50 = 0.3 μM) and reduces the production of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-a) in THP1 cells. The binding mode of compound 6 in GPBAR1 was elucidated by docking calculations. Moreover, compound 6 protects against TNBSinduced colitis in Gpbar1+/+ rodent model, representing an intriguing lead for the treatment of these inflammatory disorders.

Method for synthesizing lithocholic acid from hyodeoxycholic acid as raw material

-

Paragraph 0021; 0029, (2019/01/23)

The invention discloses a method for synthesizing a lithocholic acid from a hyodeoxycholic acid as the raw material. The hyodeoxycholic acid is used as the starting material, the lithocholic acid is produced through the seven reaction steps of 24-carboxylesterification, carboxylation of 3alpha-hydroxyl and 6alpha-hydroxyl through oxidation, selective reduction, acylation, hydrazone formation, hydrazoneremoval, and hydrolysis. The starting material is cheap and easy to get, no hydrazine hydrate is used in the synthesis process, the technological conditions for synthesis are safe, environmentally friendly and mild, the total yield is relatively high, and the method is suitable for industrial production.

1,3-Dibromo-5,5-dimethylhydantoin as a Precatalyst for Activation of Carbonyl Functionality

?ebular, Klara,Bo?i?, Bojan ?.,Stavber, Stojan

supporting information, (2019/08/01)

Activation of carbonyl moiety is one of the most rudimentary approaches in organic synthesis and is crucial for a plethora of industrial-scale condensation reactions. In esterification and aldol condensation, which represent two of the most important reactions, the susceptibility of the carbonyl group to nucleophile attack allows the construction of a variety of useful organic compounds. In this context, there is a constant need for development of and improvement in the methods for addition-elimination reactions via activation of carbonyl functionality. In this paper, an advanced methodology for the direct esterification of carboxylic acids and alcohols, and for aldol condensation of aldehydes using widely available, inexpensive, and metal-free 1,3-dibromo-5,5-dimethylhydantoin under neat reaction conditions is reported. The method is air- and moisture-tolerant, allowing simple synthetic and isolation procedures for both reactions presented in this paper. The reaction pathway for esterification is proposed and a scale-up of certain industrially important derivatives is performed.

Synthetic method for 6-carbonyl lithocholic acid

-

Paragraph 0026; 0031, (2019/02/19)

The invention discloses a synthetic method for 6-carbonyl lithocholic acid. The synthetic method comprises the following steps of by adopting hyodeoxycholic acid as a starting material, sequentially performing 4-step reaction of 24-carboxyl esterification, oxidization of 3 alpha-OH and 6 alpha-OH into carbonyl groups, selective reduction and hydrolyzation to obtain a target product. The synthetictechnology is simple in flow, liable to control, wide in raw material source and available in raw material and can realize mass production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2868-48-6